Skip to main content
. 2026 Mar 18;19(3):297–310. doi: 10.2174/0118723128441303260129080416

Table 1.

List of compounds and relevant physicochemical properties.

Compound Structure Molecular Weight
(Free Base)
Class pKa LogD
(pH 7.4)
Axitinib graphic file with name DMB-19-3-297-t1-1.jpg 386.47 Basic 4.85 (B1), 11.93 (A1) 3.57
Clozapine graphic file with name DMB-19-3-297-t1-2.jpg 326.83 Basic 3.96 (B1), 7.62 (B2) 2.78
Dasatinib graphic file with name DMB-19-3-297-t1-3.jpg 488.01 Basic 3.01 (B1), 6.93 (B2), 10.65 (A1) 2.98
Dexamethasone graphic file with name DMB-19-3-297-t1-4.jpg 392.47 Neutral NA 1.99
Erlotinib graphic file with name DMB-19-3-297-t1-5.jpg 393.44 Basic 5.37 (B1) 3.21
Fluconazole graphic file with name DMB-19-3-297-t1-6.jpg 306.28 Basic 2.56 (B1), 2.94 (B2), 11.01 (A1) 0.52
Fluphenazine graphic file with name DMB-19-3-297-t1-7.jpg 437.53 Basic 3.57 (B1), 7.63 (B2) 3. 75
Imatinib graphic file with name DMB-19-3-297-t1-8.jpg 493.62 Basic 1.93 (B1), 3.16 (B2), 4.12 (B3), 7.89 (B4) 2. 42
Ketoconazole graphic file with name DMB-19-3-297-t1-9.jpg 551.48 Basic 3.35 (B1), 6.38 (B2) 3.59
Lapatinib graphic file with name DMB-19-3-297-t1-10.jpg 581.06 Basic 4.57 (B1), 5.87 (B2) 3.81
Propranolol graphic file with name DMB-19-3-297-t1-11.jpg 259.35 Basic 9.58 (B1) 1.18
Sildenafil graphic file with name DMB-19-3-297-t1-12.jpg 474.58 Basic 6.5 (B1), 9.2 (A1) 2.81
Sulfamethoxazole graphic file with name DMB-19-3-297-t1-13.jpg 253.28 Acidic 1.55 (B1), 5.62 (A1) -0.62
Sunitinib graphic file with name DMB-19-3-297-t1-14.jpg 398.48 Basic 8.89 (B1) 2.43
Tolbutamide graphic file with name DMB-19-3-297-t1-15.jpg 270.35 Acidic 5.52 (A1) 0.32
Nelfinavir Inline graphic
Inline graphic
567.79 Acidic 9.32 (A1)*
8.18 (B1)*
4.72*
Ritonavir graphic file with name DMB-19-3-297-t1-18.jpg 720.95 Acidic 2.84 (B1)* 5.22*

Note: B1, B2, B3, and B4 denote different basic sites within the same molecule; A1 denotes the first acidic site (if more than one is present). pKa for fluconazole and sildenafil were obtained from the study by Corrêa et al. 2012 [38] and Akula & Lakshmi 2018 [39], respectively. *Data sourced from https://go.drugbank.com.